More Evidence Showing Vitamin D Combats Cancer

0
728

by Dr. Joseph Mercola, Mercola:

STORY AT-A-GLANCE
  • Evidence continues to accumulate showing that vitamin D is a strong ally to combat cancer
  • Low vitamin D levels are linked to an increased risk of cancers, while vitamin D can attach to the vitamin D receptor (VDR) in your cells, setting off a series of signals that may affect how they grow, develop and survive
  • Although increasing vitamin D levels may help to reduce cancer deaths, health officials rarely recommend optimizing levels for this purpose

TRUTH LIVES on at https://sgtreport.tv/

  • Vitamin D targets cancer in multiple ways, including anticancer, antimetastatic and anti-tumorigenic effects
  • The best way to optimize your vitamin D level is via regular sun exposure, which enhances production of melatonin — a potent anticancer agent

I strongly recommend getting sensible sun exposure each day, and one of the reasons why is because it helps naturally optimize your vitamin D levels. Low vitamin D levels are linked to an increased risk of cancers,1 while vitamin D can attach to the vitamin D receptor (VDR) in your cells, setting off a series of signals that may affect how they grow, develop and survive.2

In this way, vitamin D acts like a brake on the process of cell growth in many tissues of the body, helping to control the speed at which cells multiply. This is particularly important when it comes to cancer because one of the key features of this disease is cells growing out of control. Moreover, vitamin D has been observed in animal studies to help delay some age-related changes by activating another important pathway via the vitamin D receptor.

This pathway involves a molecule called Nrf2, which plays a crucial role in protecting your body from oxidative stress and DNA damage — two factors that are commonly linked to the development of cancer.3 Overall, evidence continues to accumulate showing that vitamin D is a strong ally to combat cancer.4

Vitamin D Reduces Cancer Mortality

Worldwide, cancer is the No. 2 cause of death, behind only cardiovascular disease.5 Meanwhile, the global prevalence of vitamin D deficiency (defined as a level of less than 20 ng/mL) and insufficiency (defined as a level of 20 to less than 30 ng/mL) is 40% to 100%.6 Although increasing vitamin D levels may help to reduce cancer deaths, health officials rarely recommend optimizing levels for this purpose.

For example, research has shown that once you reach a minimum serum vitamin D level of 40 ng/mL, your risk for cancer diminishes by 67%, compared to having a level of 20 ng/mL or less.7

A 2023 systematic review and meta-analysis published in Ageing Research Reviews also found vitamin D3 supplementation reduced cancer mortality by 6%. This wasn’t considered statistically significant, but when only studies involving daily vitamin D intake were analyzed, cancer mortality dropped by a significant 12%.8 According to the researchers:9

“From a biological perspective, it is plausible that a sufficient vitamin D status has an impact on cancer prognosis: by binding to the vitamin D receptor (VDR), the active hormone 1,25-dihydroxyvitamin D (1,25(OH)2D) influences signaling pathways that regulate cell proliferation, differentiation, and cell survival, and thus acts as an anti-proliferative agent in many tissues and can slow the growth of malignant cells.”

Other research also supports vitamin D’s role in protecting against cancer death. In one study of 25,871 patients, vitamin D supplementation was found to reduce the risk for metastatic cancer and death by 17%. The risk was reduced by as much as 38% among those who also maintained a healthy weight.10,11

What’s particularly noteworthy is this study only gave participants 2,000 IU of vitamin D daily and didn’t measure their blood levels. Despite these research flaws, a significant benefit was still found. However, other research has found even more striking benefits, including a GrassrootsHealth analysis published in PLOS ONE.

It showed women with a vitamin D level at or above 60 ng/mL (150 nmol/L) had an 82% lower risk of breast cancer compared to those with levels below 20 ng/mL (50 nmol/L).12 Meanwhile, risks of lung cancer, colorectal cancer, breast cancer, bladder cancer and lymphoma are higher in people with low vitamin D levels, while having higher levels is associated with a better prognosis in cases of breast and colorectal cancers.13

The Ageing Research Reviews study further revealed that daily vitamin D supplementation was particularly beneficial for people aged 70 and over, as well as those who took vitamin D daily and were later diagnosed with cancer. Study author Ben Schöttker, Ph.D., with the German Cancer Research Center in Heidelberg, further explained:14

“This does imply that basically everyone aged 50 and older, including people who have never had cancer, might profit from vitamin D supplementation if they are vitamin D insufficient … Doctors cannot know who might develop cancer at a later time.”

Vitamin D Has Anticancer Effects Against Many Types of Cancer

A mini review on the impact of vitamin D on cancer, published in The Journal of Steroid Biochemistry and Molecular Biology, pointed out that while vitamin D is widely recognized for its essential role in regulating the balance of minerals in the body, a deficiency has been linked to the onset and progression of various cancers.15 Vitamin D targets cancer in multiple ways, including:16

  • Anticancer effects, which means it targets different stages of cancer development and progression, including the initiation, growth and spread of cancer cells.
  • Antimetastatic effects, which refers to the ability to stop cancer cells from spreading from the original tumor site to other parts of the body. Since metastasis is often responsible for the fatal outcomes of cancers, preventing the spread can significantly improve survival rates.
  • Anti-tumorigenic, meaning vitamin D helps prevent tumor formation or the growth of tumors. This can involve mechanisms like inducing cell death in cancer cells, blocking cell cycle progression, or inhibiting pathways that fuel tumor growth.

The review highlighted vitamin D’s role against the following cancers:17

Breast Prostate Bladder
Colon Glioblastoma Melanoma
Squamous cell carcinoma Ovarian Multiple myeloma
Osteosarcoma Head and neck

In terms of breast cancer, the leading cause of death for women globally, vitamin D deficiency is common among patients, and those who are deficient are more likely to have more aggressive and harder-to-treat subtypes of breast cancer, such as higher grade and estrogen receptor-negative tumors.

The study also highlighted the role of genetic differences in the VDR that could influence breast cancer risk. In particular, in certain populations like North Indian women from New Delhi, variations in the VDR gene were identified as potential risk factors.18

In prostate cancer — the most common cancer in men — low levels of vitamin D were linked to high levels of dihydrotestosterone (DHT) in the prostate which is associated with the progression of prostate cancer.19 In addition, vitamin D may influence the activity of sirtuin 1 (SIRT1), which is known as a longevity protein. Optimizing your vitamin D levels may help boost your body’s natural cancer defenses, in part, via mechanisms involving SIRT1.20

Additional research suggests there may be considerable variation in how different individuals’ genes respond to vitamin D supplementation, which might explain why not everyone benefits equally from extra vitamin D.

For best results, the scientists suggest vitamin D supplementation should be personalized and “advocate for options tailored to individual vitamin D needs, combined with a comprehensive intervention that favors prevention through a healthy environment and responsible health behaviors.”21

Read More @ Mercola.com